Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
OurCrowd to Back Israeli Covid-19 Vaccine Company in $12 Million Round
Error: Contact form not found.
by Elham Nasser Eddin
A medical worker wearing a protective mask and suit treats patients suffering from coronavirus disease (COVID-19) in an intensive care unit at the Oglio Po hospital in Cremona, Italy, March 19, 2020. Photo: Reuters / Flavio Lo Scalzo.
CTech – Jerusalem-based equity crowdfunding company OurCrowd will lead a $12 million investment round for newly formed Covid-19 vaccine company MigVax, the company announced in a statement on Wednesday.
MigVax intends to use the funds to accelerate the development of a coronavirus vaccine and bring it to the market.
“We are humbled by the opportunity to invest in this company, which means so much to so many people. The race for a Covid-19 vaccine is about saving countless lives, and we are grateful to be able to support this important effort,” said OurCrowd CEO Jon Medved.
Labs around the world are racing to find a coronavirus vaccine. According to The Independent, the UK plans to begin human trials on a Covid-19 vaccine, developed by the University of Oxford, on Thursday.
Israel-based MigVax is an affiliate of Migal Galilee Research Institute, which specializes in biotechnology, computer sciences, plant science, agriculture, and environmental sciences. The multi-disciplinary research institute has previously developed a vaccine against bronchitis.
